AstraZeneca is one of only a handful of pure-play biopharmaceutical companies to span the entire value chain of a medicine from discovery, early- and late-stage development to manufacturing and distribution, and the global commercialisation of primary care, specialty care-led and specialty care medicines that transform lives. Read more at astrazeneca.com
David Wilson, PhD, VP Biologics, Teva Pharmaceuticals
A. Maria Dahl
Executive Business Development Director, AstraZeneca + more
My responsibilities are for negotiating oncology licensing and collaboration agreements. I have more than 12 years experience in business development and portfolio management from the US and UK pharmaceutical and biotech industry. I have also been a non-executive director on the board of a private UK biotech company, and also previously co-chaired or been a jury member in US and French business plan competitions.
Executive Director, Oncology Innovative Medicines & Early Development, AstraZeneca + more
I'm responsible for development and delivery of AstraZeneca’s portfolio of Stratified Medicine Studies, partnered Stratified Medicine initiatives (National, European, US, Asia) and basket studies, and Senior Project Director in Oncology Early Clinical Development. I have >20 years experience in drug and therapeutics development across industry (AstraZeneca, Roche/Genentech) and academic (University College London, King’s College London) careers focused in clinical and translational science, and personalised healthcare in oncology, inflammation and cardio-/vascular fields.
Associate Director, Partnering & Strategy, MedImmune + more
After joining MedImmune, I initially focused on the fibrosis research efforts, both internally and with external collaborators and have since gained an MBA. I'm now Partnering & Strategy group at MedImmune and my research interests span the underlying pathways promoting the effects of injury, inflammation and I have successfully transitioned 3 therapeutics into Ph2.
Scientific Partnering and Alliances, AstraZeneca + more
Scientific Partnering and Alliances supporting the Oncology iMED and the Emerging Innovations Unit (EIU), a virtualized, externally focused R&D team. This includes negotiation and execution of any and all agreements related to early stage small molecule oncology assets and the out licensing of phase 2b ready EIU assets.
Academic Alliances Manager, Scientific Partnering & Alliances, AstraZeneca + more
Experienced Business Development professional with keen interest in new models of collaborative working and open innovation between academia, the charity sector and industry.
Specialities: Open Innovation, Drug Discovery, Medical Technologies, Technology Transfer, IP Management, Technical Due Diligence and Evaluation, Networking, Agreement Negotiation, Consortia Drafting
Head of the Medlmmune Cambridge department of Clinical Pharmacology and DMPK (CPD), one of three global Medlmmune sites providing PKPD, pharmacometrics and bioanalytical support for the biotherapeutic products pipeline.
Responsible for establishing strategy, direction, and objectives for the CPD site, and ensuring progress towards objectives.
Accountable for all aspects of CPD for products at discovery, nonclinical and clinical stages of development
Collaborate with bioanalytical and translational CPD scientists on the development, validation, and conduct of PK, immunogenicity, and biomarker assays.
Active contributor to R&D and corporate governance committees and the strategic direction of the broader research organization, including harmonization between sites.
Vice President. Global Commercial Learning Academy at AstraZeneca + more
A global pharmaceutical business leader experienced in marketing, sales, commercial operations and corporate affairs. Demonstrated ability and track record of building, leading and motivating large cross-functional teams across geographical boundaries and cultures. Demonstrated ability to lead innovation and change in large organisations and teams. More than 22 years experience in the pharmaceutical industry with more than 10 years in senior roles